Listed

Relmada Therapeutics, Inc.: Form 8-K, filed Feb 5, 2018

Filed with the SEC on Feb 5, 2018 and accepted by EDGAR at Feb 5, 2018, 16:59 ET.

Share

Items reported

  • Item 5.07 Shareholder vote results

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Source: SEC EDGAR, the filing index for accession 0001213900-18-001309. Last ingested by Listed: Nov 13, 2026, 15:42 ET. Listed shows no prices and gives no investment advice.